EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma

María Belén García-Ortega, Ernesto Aparicio, Carmen Griñán-Lisón iD, Gema Jiménez iD, Elena López-Ruiz iD, José Luis Palacios, Gloria Ruiz-Alcalá, Cristina Alba, Antonio Martínez, Houria Boulaiz iD, Macarena Perán iD, Michael Hackenberg iD und 4 weitere

Cancers · 18.07.2023 · 15 (14) · 3666

DOI: 10.3390/cancers15143666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 18.07.2023. Verfasst von María Belén García-Ortega und 15 weiteren Autor:innen. Beteiligte Einrichtung: Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research, University of Granada, 18016 Granada, Spain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejería de Economía, Empleo y Competitividad Comunidad de Madrid, Consejería de Salud y Familias, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant melanoma (MM) can spread to other organs and is resistant in part due to the presence of cancer stem cell subpopulations (CSCs). While a controversial high dose of interferon-alpha (IFN-α) has been used to treat non-metastatic high-risk melanoma, it comes with undesirable side effects. In this study, we evaluated the effect of low and high doses of IFN-α on CSCs by analyzing ALDH activity, side population and specific surface markers in established and patient-derived primary cell lines. We also assessed the clonogenicity, migration and tumor initiation capacities of IFN-α treated CSCs. Additionally, we investigated genomic modulations related to stemness properties using microRNA sequencing and microarrays. The effect of IFN-α on CSCs-derived exosomes was also analyzed using NanoSight and liquid chromatography (LC-HRMS)-based metabolomic analysis, among others. Our results showed that even low doses of IFN-α reduced CSC formation and stemness properties, and led to a significant decrease in the ability to form tumors in mice xenotransplants. IFN-α also modulated the expression of genes and microRNAs involved in several cancer processes and metabolomics of released exosomes. Our work suggests the utility of low doses of interferon, combined with the analysis of metabolic biomarkers, as a potential clinical approach against the aggressiveness of CSCs in melanoma.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscancer stem cellsexosomesinterferon-αmalignant melanomametabolomics

Autor:innen und Institutionen

  • Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research, University of Granada, 18016 Granada, Spain.
  • Instituto de Investigación Biosanitaria de Granada (ibs. GRANADA), 18012 Granada, Spain.
  • Excellence Research Unit "Modelling Nature" (MNat), University of Granada, 18071 Granada, Spain.
  • Department of Oncology, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
  • Department of Genetics, University of Granada, 18100 Granada, Spain.
  • Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, 18011 Granada, Spain.

ORCID-Profile: Carmen Griñán-Lisón, Gema Jiménez, Elena López-Ruiz, Houria Boulaiz, Macarena Perán, Michael Hackenberg, José Bragança, Juan A Marchal, María Ángel García

Förderung

  • Consejería de Economía, Empleo y Competitividad Comunidad de Madrid
  • Consejería de Salud y Familias
  • Ministerio de Ciencia, Innovación y Universidades
  • Instituto de Salud Carlos III
  • Consejería de Economía, Conocimiento, Empresas y Universidad de la Junta de Andalucía
  • Consejería de Salud y Familias de la Junta de Andalucía
  • Chair “Doctors Galera-Requena in cancer stem cell research”
  • MICIU

Zitieren

APA

García-Ortega, M. B., Aparicio, E., Griñán-Lisón, C., Jiménez, G., López-Ruiz, E., Palacios, J. L., Ruiz-Alcalá, G., Alba, C., Martínez, A., Boulaiz, H., Perán, M., Hackenberg, M., Bragança, J., Calado, S. M., Marchal, J. A., & García, M. Á. (2023). Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma. Cancers, 15(14), 3666. https://doi.org/10.3390/cancers15143666

Vancouver

García-Ortega MB, Aparicio E, Griñán-Lisón C, Jiménez G, López-Ruiz E, Palacios JL, et al. Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma. Cancers. 2023;15(14):3666. doi:10.3390/cancers15143666

BibTeX
@article{GarcaOrtega2023,
  author = {García-Ortega, María Belén and Aparicio, Ernesto and Griñán-Lisón, Carmen and Jiménez, Gema and López-Ruiz, Elena and Palacios, José Luis and Ruiz-Alcalá, Gloria and Alba, Cristina and Martínez, Antonio and Boulaiz, Houria and Perán, Macarena and Hackenberg, Michael and Bragança, José and Calado, Sofia M and Marchal, Juan A and García, María Ángel},
  title = {Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {14},
  pages = {3666},
  doi = {10.3390/cancers15143666}
}
Kostenlos starten →